Content about Acetates

MORRISTOWN, N.J. — To encourage consumers to rethink aspirin for pain relief — according to a recent Bayer survey, only 8% of respondents reported taking aspirin more often that other OTC pain relievers — Bayer on Tuesday issued the Fast Relief Challenge and is giving away 100,000 bottles of Bayer Advanced Aspirin so consumers can put the pain reliever to the test.

LAS VEGAS — Annapolis, Md.-based St. Joseph Consumer Health last week unveiled a new St. Joseph-branded line of cough-cold products formulated for patients with high blood pressure at the ECRM Cough & Cold and Allergy EPPS.

The products all feature "decongestant-free" on the package underneath the St. Joseph brand, long known for its 81-mg daily aspirin regimen. The lineup includes a multi-symptom day/night caplet formulation, two formulations targeting cold and flu symptoms and a cough tablet SKU.

NEW YORK — A new study published in the July 19 online edition of BMJ found that heart disease patients that opt out of taking low-dose aspirin daily put themselves at a higher risk for heart attack.

HOUSTON — A recent clinical trial involving a new drug formulation incorporating aspirin with soy-derived phosphatidylcholine found that the drug combination significantly can reduce irritation to the stomach and upper gastrointestinal tract.

LONDON — Daily aspirin use may curb cancer-related deaths, according to a new study published in The Lancet.

The study, led by Peter Rothwell of the University of Oxford and colleagues, analyzed data from eight eligible trials — which typically lasted about four years — and included more than 25,000 subjects. Among them, 674 died from cancer.

MINNEAPOLIS Preventative health services, such as daily aspirin use, tobacco-cessation screening and alcohol-abuse screening potentially can save 2 million lives and nearly $4 billion annually, according to a new paper produced by the National Commission on Prevention Priorities.